查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876743

腸道健康和益生菌補充劑市場預測至2032年：按產品、成分、通路、最終用戶和地區分類的全球分析

Gut Health & Probiotic Supplements Market Forecasts to 2032 - Global Analysis By Product (Dietary Supplements, Functional Foods, Functional Beverages and Other Products), Ingredient, Distribution Channel, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，全球腸道健康和益生菌補充劑市場預計將在 2025 年達到 91 億美元，並在 2032 年達到 173 億美元，在預測期內以 9.5% 的複合年成長率成長。

腸道健康和益生菌補充劑指的是消化器官系統的平衡和正常功能，它在消化、營養吸收和免疫防禦中發揮關鍵作用。健康的腸道內棲息著多種有益微生物，它們支持代謝和免疫功能。益生菌補充劑是活性細菌和酵母，它們透過補充有益微生物來恢復和維持這種平衡，從而幫助改善消化、增強免疫力並預防消化器官系統疾病。定期服用益生菌有助於促進腸道菌叢的健康，減少炎症，並支持身體的自然防禦機制，從而增進整體健康。

消費者對預防保健和健康產品的需求

在全球範圍內，人們對預防保健和改善健康的需求推動了益生菌補充劑的流行。消費者對消化系統健康、免疫力和整體健康的日益重視，促使他們開始每天服用益生菌。機能性食品和補充劑擴大被作為綜合健康方案的一部分進行推廣。健康專家推薦益生菌作為傳統治療方法的輔助手段，進一步提升了其可信度。這種將消費者健康需求與預防性營養結合的趨勢，持續推動益生菌產品的成長。

高昂的研發成本和監管障礙使得健康聲明面臨挑戰。

研發成本和監管壁壘限制了益生菌生產商的擴張。開發經臨床檢驗的菌株需要大量投資於測試和配方研發。監管機構對健康聲明製定了嚴格的指導方針，導致產品上市延遲和合規成本增加。由於資源有限，小規模的公司在與現有企業競爭時面臨重重障礙。儘管市場需求不斷成長，但這些限制因素仍阻礙創新和市場擴張。

與個人化營養和基於DNA的健康理念相結合

個人化營養和基於DNA的健康管理正在提升消費者參與度和產品差異化。企業正在拓展其微生物組檢測套組線，並結合個人化訂製的益生菌配方。人工智慧驅動的平台能夠根據基因和生活方式數據提供個人化建議。膳食補充劑公司與數位健康Start-Ups之間的合作正在加速創新。這項機會正在為益生菌領域開闢新的收入來源，並增強消費者忠誠度。

保存期限穩定性和低溫運輸要求

保存期限穩定性及低溫運輸要求限制了益生菌產品的分銷和價格承受能力。活性益生菌菌株需要受控的儲存條件才能維持其功效。新興市場基礎設施​​不足限制了產品的供應和穩定性。高昂的物流成本降低了益生菌產品與傳統膳食補充劑相比的競爭力。這些挑戰持續阻礙益生菌產品的全球推廣和長期普及。

新冠疫情的感染疾病：

新冠感染疾病加速了益生菌的需求，因為消費者更加重視免疫力和預防性保健。疫情加速了已開發市場和新興市場對益生菌補充劑的接受度。雖然封鎖措施擾亂了供應鏈和分銷，但線上管道迅速擴張以彌補損失。各大品牌將行銷重點放在免疫力上，並將益生菌定位為必需的健康產品。疫情後的復甦階段，結合零售和電商的混合分銷模式蓬勃發展。這種影響持續改變消費者的行為，並強化了益生菌在預防性保健中的重要角色。

預計在預測期內，膳食補充劑細分市場將佔據最大的市場佔有率。

由於消費者對便捷的日常益生菌攝取需求不斷成長，預計膳食補充劑領域在預測期內將佔據最大的市場佔有率。無論是膠囊、片劑或粉末形式的膳食補充劑，都在推動益生菌的普及。消費者青睞補充劑，是因為它們便於攜帶、劑量精準且易於融入日常生活。健康專家也擴大推薦補充劑來促進消化器官系統和免疫健康。零售店和線上通路的廣泛普及進一步推動了益生菌的推廣。憑藉其便利性和廣泛的消費者吸引力，該領域將繼續保持主導地位。

預計在預測期內，芽孢桿菌細分市場將呈現最高的複合年成長率。

由於其穩定性和多功能性，芽孢桿菌細分市場預計將在預測期內實現最高成長率。芽孢桿菌菌株正在推動益生菌製劑在膳食補充劑和機能性食品領域的成長。與其他菌株不同，芽孢桿菌能夠耐受嚴苛的加工和儲存條件，從而降低對低溫運輸的依賴。其形成孢子的特性延長了保存期限，並增強了其全球分銷潛力。對芽孢桿菌在腸道環境和免疫功能方面功效的研究不斷深入，正在加速其應用。由於擴充性和韌性，預計該細分市場將超越其他細分市場。

佔比最大的地區：

在預測期內，北美預計將憑藉其先進的基礎設施和較高的消費者意識佔據最大的市場佔有率。對預防性保健和機能性食品的強勁需求正在推動益生菌的普及。領先的營養保健品公司正在加大研發投入並拓展產品系列。監管環境的明朗化和消費者可支配收入的提高正在推動市場成熟。電子商務的興起和健康意識行銷的普及正在加速益生菌的推廣。北美將繼續在收入和創新方面保持領先地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將成為複合年成長率最高的地區，這主要得益於快速的都市化和日益增強的健康意識。中國、日本、印度和東南亞的強勁需求正在推動益生菌市場的成長。本土Start-Ups公司和全球公司正在不斷拓展其價格親民且符合當地文化習慣的益生菌產品線。中產階級收入的成長和數位技術的普及正在加速市場滲透。政府對預防性醫療保健和營養的支持正在推動益生菌市場的長期成長。

免費客製化服務：

購買此報告的客戶可以選擇以下免費自訂選項之一：

  • 公司概況
    • 對其他市場公司（最多 3 家公司）進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域細分
    • 根據客戶要求，對主要國家的市場規模和複合年成長率進行估算和預測（註：可行性需確認）。
  • 競爭基準化分析
    • 根據主要企業的產品系列、地理覆蓋範圍和策略聯盟基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 研究途徑
  • 研究材料
    • 原始研究資料
    • 次級研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間的競爭

5. 全球腸道健康和益生菌補充劑市場（按產品分類）

  • 介紹
  • 營養補充品
  • 機能性食品
  • 機能飲料
  • 動物飼料用益生菌
  • 嬰兒營養產品
  • 臨床營養產品
  • 寵物營養及伴侶動物性產品
  • 其他產品

6. 全球腸道健康和益生菌補充劑市場（按成分分類）

  • 介紹
  • 乳酸菌
  • 雙歧桿菌
  • 釀酒酵母
  • 鏈球菌
  • 芽孢桿菌
  • 腸球菌
  • 其他成分

7. 全球腸道健康和益生菌補充劑市場（按通路管道分類）

  • 介紹
  • 藥房和藥品商店
  • 超級市場和大賣場
  • 線上平台
  • 專業保健食品店
  • 便利商店和雜貨店
  • 其他通路

8. 全球腸道健康和益生菌補充劑市場（按最終用戶分類）

  • 介紹
  • 成人
  • 孩子
  • 老年人
  • 獸用
  • 孕婦及哺乳期婦女
  • 其他最終用戶

9. 全球腸道健康和益生菌補充劑市場（按地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：重大進展

  • 協議、夥伴關係、合作和合資企業
  • 收購與併購
  • 新產品上市
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Nestle Health Science
  • Danone SA
  • Chr. Hansen Holding A/S
  • DuPont de Nemours Inc.
  • Kerry Group plc
  • Yakult Honsha Co. Ltd.
  • Amway Corporation
  • Bayer AG
  • BioGaia AB
  • DSM-Firmenich AG
  • Probi AB
  • Arla Foods amba
  • General Mills Inc.
  • NOW Foods
  • Garden of Life LLC
Product Code: SMRC32395

According to Stratistics MRC, the Global Gut Health & Probiotic Supplements Market is accounted for $9.1 billion in 2025 and is expected to reach $17.3 billion by 2032 growing at a CAGR of 9.5% during the forecast period. Gut Health & Probiotic Supplements refer to the balance and proper functioning of the gastrointestinal system, which plays a crucial role in digestion, nutrient absorption, and immune defense. A healthy gut contains a diverse community of beneficial microorganisms that support metabolic and immune functions. Probiotic supplements are live bacteria and yeasts that help restore and maintain this balance by replenishing beneficial microbes. They aid in improving digestion, enhancing immunity, and preventing gastrointestinal disorders. Regular consumption of probiotics contributes to overall wellness by promoting a healthy microbiome, reducing inflammation, and supporting the body's natural defense mechanisms.

Market Dynamics:

Driver:

Consumer demand for preventive healthcare and wellness products

Preventive healthcare and wellness demand is boosting adoption of probiotic supplements globally. Rising awareness of digestive health, immunity, and overall well-being is propelling consumers toward daily probiotic intake. Functional foods and supplements are increasingly marketed as part of holistic wellness routines. Healthcare professionals are recommending probiotics as adjuncts to conventional treatments, further strengthening credibility. This driver continues to anchor growth by aligning consumer health priorities with preventive nutrition.

Restraint:

High R&D costs and regulatory hurdles for health claims

R&D costs and regulatory hurdles are limiting scalability for probiotic manufacturers. Developing clinically validated strains requires significant investment in trials and formulation. Regulatory bodies impose strict guidelines on health claims, delaying product launches and increasing compliance costs. Smaller companies face barriers in competing with established players due to limited resources. This restraint continues to constrain innovation and market expansion despite rising demand.

Opportunity:

Integration with personalized nutrition and DNA-based wellness

Personalized nutrition and DNA-based wellness are enhancing consumer engagement and product differentiation. Companies are increasingly offering microbiome testing kits linked to tailored probiotic formulations. AI-driven platforms are enabling personalized recommendations based on genetic and lifestyle data. Partnerships between nutraceutical firms and digital health startups are accelerating innovation. This opportunity is unlocking new revenue streams and strengthening consumer loyalty in the probiotic sector.

Threat:

Shelf-life stability and cold-chain requirements

Shelf-life stability and cold-chain requirements are constraining distribution and affordability. Live probiotic strains require controlled storage conditions to maintain efficacy. Inadequate infrastructure in emerging markets limits product availability and consistency. High logistics costs reduce competitiveness compared to conventional supplements. This threat continues to challenge global expansion and long-term adoption of probiotics.

Covid-19 Impact:

Covid-19 accelerated demand for probiotics as consumers prioritized immunity and preventive health. Covid-19 boosted probiotic supplement adoption across both developed and emerging markets. Lockdowns disrupted supply chains and distribution, but online channels compensated with rapid growth. Brands leveraged immunity-focused marketing to position probiotics as essential wellness products. Post-pandemic recovery is fostering hybrid distribution models combining retail and e-commerce. This impact continues to reshape consumer behavior and strengthen probiotics' role in preventive healthcare.

The dietary supplements segment is expected to be the largest during the forecast period

The dietary supplements segment is expected to account for the largest market share during the forecast period owing to rising demand for convenient, daily probiotic intake. Dietary supplements are driving adoption of probiotics across capsules, tablets, and powders. Consumers favor supplements for their portability, dosage accuracy, and ease of integration into routines. Healthcare professionals increasingly recommend supplements for digestive and immune health. Expanding retail and online availability is accelerating adoption. This segment continues to dominate due to its accessibility and broad consumer appeal.

The bacillus segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the bacillus segment is predicted to witness the highest growth rate due to its stability and versatility. Bacillus strains are driving growth in probiotic formulations across supplements and functional foods. Unlike other strains, bacillus can withstand harsh processing and storage conditions, reducing cold-chain dependency. Their spore-forming nature enhances shelf-life and global distribution potential. Rising research on bacillus efficacy in gut health and immunity is accelerating adoption. This segment is expected to outpace others due to its scalability and resilience.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share due to advanced infrastructure and high consumer awareness. North America is driving probiotic adoption through strong demand for preventive healthcare and functional foods. Leading nutraceutical companies are investing in R&D and expanding product portfolios. Regulatory clarity and high disposable incomes are fostering market maturity. E-commerce penetration and wellness-focused marketing are accelerating adoption. North America continues to dominate in both revenue and innovation leadership.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR owing to rapid urbanization and rising health consciousness. Asia Pacific is driving probiotic growth through strong demand in China, Japan, India, and Southeast Asia. Local startups and global players are scaling affordable and culturally tailored probiotic products. Rising middle-class incomes and digital adoption are accelerating market penetration. Government support for preventive healthcare and nutrition is fostering long-term growth.

Key players in the market

Some of the key players in Gut Health & Probiotic Supplements Market include Nestle Health Science, Danone S.A., Chr. Hansen Holding A/S, DuPont de Nemours Inc., Kerry Group plc, Yakult Honsha Co. Ltd., Amway Corporation, Bayer AG, BioGaia AB, DSM-Firmenich AG, Probi AB, Arla Foods amba, General Mills Inc., NOW Foods and Garden of Life LLC.

Key Developments:

In June 2025, Danone acquired The Akkermansia Company (TAC), a Belgian biotech pioneer specializing in next-generation biotics, for approximately $200 million. TAC's patented strain Akkermansia muciniphila MucT(TM) has been clinically validated to support gut barrier function, reduce inflammation, and address metabolic disorders such as obesity and diabetes.

In April 2024, Nestle India and Dr. Reddy's Laboratories formed a joint venture to bring nutraceutical and probiotic brands to consumers across India and agreed territories. This collaboration strengthens Nestle's presence in gut health by combining its global nutrition expertise with Dr. Reddy's pharmaceutical distribution network.

Products Covered:

  • Dietary Supplements
  • Functional Foods
  • Functional Beverages
  • Animal Feed Probiotics
  • Infant & Child Nutrition Products
  • Clinical Nutrition Products
  • Pet Nutrition & Companion Animal Products
  • Other Products

Ingredients Covered:

  • Lactobacillus
  • Bifidobacterium
  • Saccharomyces
  • Streptococcus
  • Bacillus
  • Enterococcus
  • Other Ingredients

Distribution Channels Covered:

  • Pharmacies & Drug Stores
  • Supermarkets & Hypermarkets
  • Online Platforms
  • Specialty Health Stores
  • Convenience & Grocery Retailers
  • Other Distribution Channels

End Users Covered:

  • Adults
  • Children
  • Geriatric Population
  • Veterinary Applications
  • Pregnant & Lactating Women
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Gut Health & Probiotic Supplements Market, By Product

  • 5.1 Introduction
  • 5.2 Dietary Supplements
  • 5.3 Functional Foods
  • 5.4 Functional Beverages
  • 5.5 Animal Feed Probiotics
  • 5.6 Infant & Child Nutrition Products
  • 5.7 Clinical Nutrition Products
  • 5.8 Pet Nutrition & Companion Animal Products
  • 5.9 Other Products

6 Global Gut Health & Probiotic Supplements Market, By Ingredient

  • 6.1 Introduction
  • 6.2 Lactobacillus
  • 6.3 Bifidobacterium
  • 6.4 Saccharomyces
  • 6.5 Streptococcus
  • 6.6 Bacillus
  • 6.7 Enterococcus
  • 6.8 Other Ingredients

7 Global Gut Health & Probiotic Supplements Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Pharmacies & Drug Stores
  • 7.3 Supermarkets & Hypermarkets
  • 7.4 Online Platforms
  • 7.5 Specialty Health Stores
  • 7.6 Convenience & Grocery Retailers
  • 7.7 Other Distribution Channels

8 Global Gut Health & Probiotic Supplements Market, By End User

  • 8.1 Introduction
  • 8.2 Adults
  • 8.3 Children
  • 8.4 Geriatric Population
  • 8.5 Veterinary Applications
  • 8.6 Pregnant & Lactating Women
  • 8.7 Other End Users

9 Global Gut Health & Probiotic Supplements Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Nestle Health Science
  • 11.2 Danone S.A.
  • 11.3 Chr. Hansen Holding A/S
  • 11.4 DuPont de Nemours Inc.
  • 11.5 Kerry Group plc
  • 11.6 Yakult Honsha Co. Ltd.
  • 11.7 Amway Corporation
  • 11.8 Bayer AG
  • 11.9 BioGaia AB
  • 11.10 DSM-Firmenich AG
  • 11.11 Probi AB
  • 11.12 Arla Foods amba
  • 11.13 General Mills Inc.
  • 11.14 NOW Foods
  • 11.15 Garden of Life LLC

List of Tables

  • Table 1 Global Gut Health & Probiotic Supplements Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Gut Health & Probiotic Supplements Market Outlook, By Product (2024-2032) ($MN)
  • Table 3 Global Gut Health & Probiotic Supplements Market Outlook, By Dietary Supplements (2024-2032) ($MN)
  • Table 4 Global Gut Health & Probiotic Supplements Market Outlook, By Functional Foods (2024-2032) ($MN)
  • Table 5 Global Gut Health & Probiotic Supplements Market Outlook, By Functional Beverages (2024-2032) ($MN)
  • Table 6 Global Gut Health & Probiotic Supplements Market Outlook, By Animal Feed Probiotics (2024-2032) ($MN)
  • Table 7 Global Gut Health & Probiotic Supplements Market Outlook, By Infant & Child Nutrition Products (2024-2032) ($MN)
  • Table 8 Global Gut Health & Probiotic Supplements Market Outlook, By Clinical Nutrition Products (2024-2032) ($MN)
  • Table 9 Global Gut Health & Probiotic Supplements Market Outlook, By Pet Nutrition & Companion Animal Products (2024-2032) ($MN)
  • Table 10 Global Gut Health & Probiotic Supplements Market Outlook, By Other Products (2024-2032) ($MN)
  • Table 11 Global Gut Health & Probiotic Supplements Market Outlook, By Ingredient (2024-2032) ($MN)
  • Table 12 Global Gut Health & Probiotic Supplements Market Outlook, By Lactobacillus (2024-2032) ($MN)
  • Table 13 Global Gut Health & Probiotic Supplements Market Outlook, By Bifidobacterium (2024-2032) ($MN)
  • Table 14 Global Gut Health & Probiotic Supplements Market Outlook, By Saccharomyces (2024-2032) ($MN)
  • Table 15 Global Gut Health & Probiotic Supplements Market Outlook, By Streptococcus (2024-2032) ($MN)
  • Table 16 Global Gut Health & Probiotic Supplements Market Outlook, By Bacillus (2024-2032) ($MN)
  • Table 17 Global Gut Health & Probiotic Supplements Market Outlook, By Enterococcus (2024-2032) ($MN)
  • Table 18 Global Gut Health & Probiotic Supplements Market Outlook, By Other Ingredients (2024-2032) ($MN)
  • Table 19 Global Gut Health & Probiotic Supplements Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 20 Global Gut Health & Probiotic Supplements Market Outlook, By Pharmacies & Drug Stores (2024-2032) ($MN)
  • Table 21 Global Gut Health & Probiotic Supplements Market Outlook, By Supermarkets & Hypermarkets (2024-2032) ($MN)
  • Table 22 Global Gut Health & Probiotic Supplements Market Outlook, By Online Platforms (2024-2032) ($MN)
  • Table 23 Global Gut Health & Probiotic Supplements Market Outlook, By Specialty Health Stores (2024-2032) ($MN)
  • Table 24 Global Gut Health & Probiotic Supplements Market Outlook, By Convenience & Grocery Retailers (2024-2032) ($MN)
  • Table 25 Global Gut Health & Probiotic Supplements Market Outlook, By Other Distribution Channels (2024-2032) ($MN)
  • Table 26 Global Gut Health & Probiotic Supplements Market Outlook, By End User (2024-2032) ($MN)
  • Table 27 Global Gut Health & Probiotic Supplements Market Outlook, By Adults (2024-2032) ($MN)
  • Table 28 Global Gut Health & Probiotic Supplements Market Outlook, By Children (2024-2032) ($MN)
  • Table 29 Global Gut Health & Probiotic Supplements Market Outlook, By Geriatric Population (2024-2032) ($MN)
  • Table 30 Global Gut Health & Probiotic Supplements Market Outlook, By Veterinary Applications (2024-2032) ($MN)
  • Table 31 Global Gut Health & Probiotic Supplements Market Outlook, By Pregnant & Lactating Women (2024-2032) ($MN)
  • Table 32 Global Gut Health & Probiotic Supplements Market Outlook, By Other End Users (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.